BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16250094)

  • 1. Many at-risk patients not getting appropriate meds. poor and inconsistent compliance with anti-thrombotic therapy guidelines reported.
    Health News; 2005 Oct; 11(10):8-9. PubMed ID: 16250094
    [No Abstract]   [Full Text] [Related]  

  • 2. Compliance with antithrombotic guidelines.
    Caprini JA; Hyers TM
    Manag Care; 2006 Sep; 15(9):49-50, 53-60, 66. PubMed ID: 17036939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Better delivery of standard antithrombotic care.
    Bussey H
    Am Heart J; 2001 Jun; 141(6):1038-42. PubMed ID: 11376321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deficient thrombosis prophylaxis].
    Holme PA
    Tidsskr Nor Laegeforen; 2007 May; 127(9):1176. PubMed ID: 17479132
    [No Abstract]   [Full Text] [Related]  

  • 5. North American and British guidelines for anti-thrombotic therapy: are we reaching consensus?
    Clark P; Bates SM
    Thromb Res; 2009; 123 Suppl 2():S111-23. PubMed ID: 19217466
    [No Abstract]   [Full Text] [Related]  

  • 6. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack.
    Schwamm LH; Fonarow GC; Reeves MJ; Pan W; Frankel MR; Smith EE; Ellrodt G; Cannon CP; Liang L; Peterson E; Labresh KA
    Circulation; 2009 Jan; 119(1):107-15. PubMed ID: 19075103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic solutions for vascular thrombotic events: summary and conclusions.
    Ouriel K
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S100-3. PubMed ID: 12556749
    [No Abstract]   [Full Text] [Related]  

  • 8. Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.
    Smalberg JH; Spaander MV; Jie KS; Pattynama PM; van Buuren HR; van den Berg B; Janssen HL; Leebeek FW
    Thromb Haemost; 2008 Dec; 100(6):1084-8. PubMed ID: 19132234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
    Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Certain cases need prolonged thrombosis prophylaxis. Four studies on hip prosthesis are in concordance].
    Bergqvist D
    Lakartidningen; 1997 Mar; 94(13):1173-4. PubMed ID: 9148052
    [No Abstract]   [Full Text] [Related]  

  • 11. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thromboprophylaxis in general surgical practices in the year 2004: perioperative use during hospitalisation, during out-patient care and following plaster cast immobilisation].
    Truijers M; Kranendonk SE; Nurmohamed MT
    Ned Tijdschr Geneeskd; 2005 Nov; 149(45):2511-6. PubMed ID: 16304889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic and thrombolytic treatments: current concepts from the North American guidelines and French practice].
    J Mal Vasc; 2005 Sep; 30 Spec No 2():2S8-2S79. PubMed ID: 16392541
    [No Abstract]   [Full Text] [Related]  

  • 14. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
    Squizzato A; Ageno W
    Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic treatment in everyday clinical practice--efficacious and safe?].
    Grond M
    Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S129-31. PubMed ID: 17089257
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based prescribing and adherence to antiplatelet therapy--how much difference do they make to patients with atherothrombosis?
    Husted S
    Int J Cardiol; 2009 May; 134(2):150-9. PubMed ID: 19282042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guideline implementation fails to improve thrombolytic administration.
    Kinsman L; Tori K; Endacott R; Sharp M
    Accid Emerg Nurs; 2007 Jan; 15(1):27-33. PubMed ID: 17218102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally applied recombinant plasmin results in effective thrombolysis in a porcine model of arteriovenous graft thrombosis.
    Hoefer IE; Stroes ES; Pasterkamp G; Levi MM; Reekers JA; Verhagen HJ; Meijers JC; Humphries JE; Rotmans JI
    J Vasc Interv Radiol; 2009 Jul; 20(7):951-8. PubMed ID: 19481472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.